Update in Lung Cancer 2005

This publication has 35 references indexed in Scilit:

• Familial Lung Cancer
  American Journal of Respiratory and Critical Care Medicine, 2006
• Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials
  Journal of Clinical Oncology, 2005
• Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib
  Journal of Clinical Oncology, 2005
• Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
  New England Journal of Medicine, 2005
• Risk of Lung Cancer Among White and Black Relatives of Individuals With Early-Onset Lung Cancer
  JAMA, 2005
• Ethnic Disparities in the Treatment of Stage I Non–Small Cell Lung Cancer
  American Journal of Respiratory and Critical Care Medicine, 2005
• Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 2005
• The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality
  Annals of Internal Medicine, 2005
• EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
  Science, 2004
• Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
  New England Journal of Medicine, 2004